AAIC 2025 Abstract
AI‐Based Hyperspectral Retinal Imaging for Alzheimer’s Disease Detection: Preliminary Insights from the Bio‐Hermes‐002 Study
Study in peopleBiomarkers
Abstract
Background: Artificial intelligence (AI)‐based retinal hyperspectral imaging (rHSI) represents a promising, non‐invasive approach to detecting Alzheimer’s disease (AD)‐related pathology, offering scalability and potential point‐of‐care utility.
